These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24476379

  • 1. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.
    Chambers AG, Percy AJ, Simon R, Borchers CH.
    Expert Rev Proteomics; 2014 Apr; 11(2):137-48. PubMed ID: 24476379
    [Abstract] [Full Text] [Related]

  • 2. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
    Percy AJ, Chambers AG, Yang J, Borchers CH.
    Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
    [Abstract] [Full Text] [Related]

  • 3. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z, Veenstra TD.
    J Proteomics; 2011 Nov 18; 74(12):2650-9. PubMed ID: 21540133
    [Abstract] [Full Text] [Related]

  • 4. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR, Zhang H, Zhao L, Wang P, Kelly-Spratt KS, Ivey RG, Piening BD, Feng LC, Kasarda E, Gurley KE, Eng JK, Chodosh LA, Kemp CJ, McIntosh MW, Paulovich AG.
    J Proteome Res; 2007 Oct 18; 6(10):3962-75. PubMed ID: 17711321
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification.
    Makawita S, Diamandis EP.
    Clin Chem; 2010 Feb 18; 56(2):212-22. PubMed ID: 20007861
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ, Yang J, Chambers AG, Mohammed Y, Miliotis T, Borchers CH.
    Adv Exp Med Biol; 2016 Feb 18; 919():515-530. PubMed ID: 27975233
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer.
    Zhao Y, Jia W, Sun W, Jin W, Guo L, Wei J, Ying W, Zhang Y, Xie Y, Jiang Y, He F, Qian X.
    J Proteome Res; 2010 Jun 04; 9(6):3319-27. PubMed ID: 20420461
    [Abstract] [Full Text] [Related]

  • 13. Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.
    Kim YJ, Sertamo K, Pierrard MA, Mesmin C, Kim SY, Schlesser M, Berchem G, Domon B.
    J Proteome Res; 2015 Mar 06; 14(3):1412-9. PubMed ID: 25597550
    [Abstract] [Full Text] [Related]

  • 14. Targeted proteomics: a bridge between discovery and validation.
    Harlan R, Zhang H.
    Expert Rev Proteomics; 2014 Dec 06; 11(6):657-61. PubMed ID: 25348939
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A, Ma PC, Salgia R.
    Mass Spectrom Rev; 2007 Dec 06; 26(3):451-66. PubMed ID: 17407130
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.